FDA Approves Oral Combination of Decitabine and Cedazuridine Tablets with Venetoclax for Newly Diagnosed AML By Ogkologos - June 3, 2026 3 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the Study ASTX727-07 Source RELATED ARTICLESMORE FROM AUTHOR Weight Loss Treatments Linked to Lower Risk of Obesity-Related Cancers in People Without Diabetes EMA Recommends Granting a Marketing Authorisation for Camizestrant ESMO Calls for the Ring-Fenced Funding of Health Under the 2028-2034 Long-Term Budget of the EU, the Multiannual Financial Framework (MFF) MOST POPULAR Cancer-Free Bell Broken by Excited Patient Who Just Got Done Battling... July 17, 2019 Study presents an AI-guided approach to target cancer antigens October 1, 2025 Overcoming a Cancer Nemesis? KRAS Inhibitor Shows Promise in Early Trial December 5, 2019 FDA Approves Melphalan As a Liver-Directed Treatment for Uveal Melanoma September 8, 2023 Load more HOT NEWS Sacituzumab Govitecan Plus Pembrolizumab Demonstrate Encouraging Activity in Patients with mUC... Breast Cancer Warrior’s Emotional Photoshoot Features Her Husband Shaving Her Head Changes in Metabolism Help Melanomas Spread Cancer in My Community: Striving to Lead People to Cancer Care...
